SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2019 Miami, FL
Activity/Course #:
: 04.27.19PC

Cost:
: Free
Release/Start Date:
: Apr 27 2019
Expiration Date:
: Apr 27 2019
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
Credit(s):
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 3.25 pharmacology hour(s)
Hardware/Software Requirements:
....

Saturday, April 27, 2019
Hilton Miami Airport
5101 Blue Lagoon Drive  
Miami, FL 33126
(305) 262-1000

Registration Fee

There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
A discounted self parking rate of $8.00 is available at the hotel.

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives
At the conclusion of this program, participants should be able to:

  1. Recognize the risk for, and impact of, hypoglycemia in patients with diabetes; Integrate strategies to reduce the risk of glycemic variability into the care of patients with diabetes; Recognize how to use SMBG or newer CGM devices to reduce the risk of dysglycemia/hypoglycemia; Differentiate between available insulin preparations and their effects on glycemic variability and hypoglycemic risk.
  2. Discuss the latest 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol to reduce the risk of cardiovascular disease; Incorporate current data surrounding non-statin therapy into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Overcome barriers to access for PCSK9 monoclonal antibody therapy.
  3. Demonstrate understanding of the burden and epidemiology surrounding HIV risk and transmission; Utilize US Public Health Service (USPHS)/US Centers for Disease Control and Prevention (CDC) clinical practice guidelines: Preexposure Prophylaxis for the Prevention of HIV Prevention in the United States to appropriately screen and determine eligibility for PrEP; Initiate a patient-provider dialog regarding sexual health and a sexual behavior assessment; Implement appropriate HIV-prevention strategies for initiation and monitoring of patients on PrEP.
  4. Recognize the pervasive nature and global impact of ADHD symptoms throughout the day; Describe the physical and psychologic morbidity and mortality associated with ADHD; Use ADHD assessment tools to aid in diagnosis, track, and measure changes in ADHD symptoms to optimize pharmacologic treatment, non-pharmacologic treatment, and symptom control throughout the day; Implement appropriate and individualized treatment regimens for patients with ADHD.
  5. Review the epidemiology and impact of pseudobulbar affect (PBA); Discuss the importance of early recognition of PBA in the primary care, nursing home, and rehabilitation settings; Describe diagnostic tools and criteria for objective diagnosis of PBA; Utilize evidence-based therapies to effectively manage PBA.
  6. Outline the pathophysiology and risk factors for TD; Describe the clinical manifestations and diagnosis of TD; Recognize the impact of TD on the patient’s quality of life; Discuss the efficacy and safety of treatment options for TD.

Agenda*

7:30-8:00 am
        
Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Gregg Sherman, MD
8:10-9:20
Insulin Therapy and Glycemic Variability: Strategies for Achieving Diabetes Goals While Minimizing Hypoglycemia
Mark Stolar, MD
9:20-10:30   A Case Based Approach to Lipids Management: Individualizing Targets and Reducing Risk
James Underberg, MD,MS, FACPM, FACP
10:30-10:50   Break
10:50-12:00 pm
  Getting PrEP’d to Talk About Sexual Health: Optimizing the PCP’s Role in HIV Prevention
Isolde Butler, MD
12:00-1:00   Lunch (on your own)
1:00-2:10   Bringing ADHD into Focus: Strategies for Individualizing Care
Birgit Amann, MD
2:10-3:20
 Crying and Laughing Inappropriately? Think Pseudobulbar Affect
Jason P. Caplan, MD, FAPA, FACLP
3:20-3:30
 Break
3:30-4:40

  Does Your Patient Have Tardive Dyskinesia? Recognition and Treatment for Improving Quality of Life
Jason P. Caplan, MD, FAPA, FACLP
4:40-4:45   Summary of Key Points and Closing Remarks
Gregg Sherman, MD

*Agenda subject to change.

Faculty

Birgit Amann, MD
Board Certified Child, Adolescent and Adult Psychiatrist
Medical Director/Founder
Behavioral Medical Center - Troy
Troy, MI

Isolde Butler, MD
Physician
CrescentCare
New Orleans, LA

Jason P. Caplan, MD, FAPA, FACLP
Chair of Psychiatry
St. Joseph’s Hospital & Medical Center
Professor of Psychiatry
Creighton University School of Medicine
Phoenix, AZ

Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL

James Underberg, MD,MS, FACPM, FACP
Lipidology & Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
President-Elect National Lipid Association
New York, NY

Moderator
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
Senior Project Manager
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
Vice President of Operations
National Association for Continuing Education

Plantation, FL

Christa Master
Vice President, Account Services
Integritas Communications Group
Hoboken, NJ

Stacey JP Ullman, MHS
Vice President, Scientific Services
Integritas Communications Group
Hoboken, NJ

Cassandra A. McCullough, MBA
Chief Executive Officer
Association of Black Cardiologists
New York, NY

Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA

Cedric Nazareth, MBBS
Medical Writer
Cedric Nazareth Medical Writing
Mississauga, ON

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7.0 contact hours of continuing education, which includes 3.25 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Avanir Pharmaceuticals; an educational grant from Gilead Sciences, Inc; an independent medical educational grant from Shire; educational funding provided by Amgen; and an educational grant from Novo Nordisk Inc.